Cystatin C adds prognostic value over conventional predictors of cardiovascular disease outcomes: Results from the long-term intervention with Pravastatin in ischaemic disease (LIPID) trial

Background Blood levels of the polypeptide, cystatin C, have been reported to be associated with increased cardiovascular mortality. However, cystatin C levels reflect renal dysfunction, and whethe...